Bio-Rad Laboratories Inc., founded in 1952 and headquartered in Hercules, California, is a global leader in life science research and clinical diagnostics. The company provides a diverse range of products and services that facilitate scientific research, testing, and quality control, including instruments, reagents, software, and quality control solutions.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| BIO 3.30% 2027-03-15 USDBio-Rad Laboratories Inc. | United States | 2027-03-15 | 3.300 | 4.15 |
| BIO 3.70% 2032-03-15 USDBio-Rad Laboratories Inc. | United States | 2032-03-15 | 3.700 | 4.77 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Bio-Rad began issuing bonds in 2013 to support its expansion and operational needs, with a notable issuance of $400 million in senior unsecured notes in 2020. These bonds typically feature investment-grade ratings, reflecting the company's strong market position, and their current yields are competitive with other entities in the biotech industry. In recent years, Bio-Rad has maintained a reputation for robust financial management, which bolsters investor confidence in its debt instruments amidst changing market conditions.